Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation - A LC-ESI-MS/MS-based proteomics approach

Blood Transfusion

Volumn 10, Issue SUPPL. 2, 2012, Pages

  Thiele, Thomas ^a   Sablewski, Armin ^a   Iuga, Christina ^a,b   Bakchoul, Tamam ^a   Bente, Andrea ^c   Görg, Siegfried ^c   Völker, Uwe ^a   Greinacher, Andreas ^a   Steil, Leif ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Amotosalen; LC ESI MS MS; Pathogen reduction; Platelet storage; Proteomics

Indexed keywords

AMOTOSALEN; CHLORIDE INTRACELLULAR CHANNEL PROTEIN 4; MEMBRANE PROTEIN; NUCLEIC ACID; NUCLEIC ACID BINDING PROTEIN; PEPTIDE; PLATELET ENDOTHELIAL AGGREGATION RECEPTOR 1; PROTEIN; PROTEIN TYROSINE SULFOTRANSFERASE 2; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG; PSORALEN DERIVATIVE;

ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD RADIATION; BLOOD SAFETY; CATALYSIS; CLINICAL EFFECTIVENESS; ELECTROSPRAY MASS SPECTROMETRY; GAMMA IRRADIATION; HUMAN; NONHUMAN; PATHOGEN CLEARANCE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEOMICS; THROMBOCYTE; ULTRAVIOLET A RADIATION; BLOOD STORAGE; DRUG EFFECT; INFECTION CONTROL; LIQUID CHROMATOGRAPHY; METHODOLOGY; RADIATION EXPOSURE; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RADIATION;

BLOOD PLATELETS; BLOOD PRESERVATION; CHROMATOGRAPHY, LIQUID; HUMANS; INFECTION CONTROL; PROTEOMICS; PSORALENS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RAYS;

EID: 84861777065     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.010S     Document Type: Article

References (26)

1. Irsch J, Lin L. Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System. Transfus Med Hemother 2011; 38: 19-31.
2. Aubuchon JP. Breathing easy with pathogen inactivation. Blood 2011; 117: 749-51.
3. Klein HG. Pathogen inactivation technology: cleansing the blood supply. J Intern Med 2005; 257: 224-37. (Pubitemid 40342125)
4. van Rhenen D, Gulliksson H, Cazenave JP, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003; 101: 2426-33. (Pubitemid 36302092)
5. McCullough J, Vesole DH, Benjamin RJ, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004; 104: 1534-41. (Pubitemid 39166535)
6. Vamvakas EC. Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system. Vox Sang 2011.
7. Schubert P, Culibrk B, Coupland D, et al. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage. Transfusion 2012; 52: 397-408.
8. Mohr H, Steil L, Gravemann U, et al. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009; 49: 2612-24.
9. Schwertz H, Tolley ND, Foulks JM, et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 2006; 203: 2433-40. (Pubitemid 44664613)
10. Schwertz H, Rowley JW, Tolley ND, et al. Assessing protein synthesis by platelets. Methods Mol Biol 2012; 788: 141-53.
11. Schlenke P, Hagenah W, Irsch J, et al. Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients. Ann Hematol 2011; 90: 1457-65.
12. Vetlesen A, Mirlashari MR, Ezligini F, Kjeldsen-Kragh J. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2007; 47: 126-32. (Pubitemid 46006320)
13. Thiele T, Steil L, Gebhard S, et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007; 47: 1221-33. (Pubitemid 46934314)
14. Thomas PD, Kejariwal A, Campbell MJ, et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 2003; 31: 334-41. (Pubitemid 36150398)
15. Mi H, Dong Q, Muruganujan A, et al. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res 2010; 38: D204-10.
16. Picker SM, Speer R, Gathof BS. Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation. Transfusion 2004; 44: 320-9. (Pubitemid 38365506)
17. Tynngard N, Studer M, Lindahl TL, et al. The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days. Transfusion 2008; 48: 1669-75.
18. Johnson AD, Yanek LR, Chen MH, et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010; 42: 608-13.
19. Kauskot A, Di Michele M, Loyen S, et al. A novel mechanism of sustained platelet alphaIIbbeta3 activation via PEAR1. Blood 2012.
20. Singh H, Ashley RH. CLIC4 (p64H1) and its putative transmembrane domain form poorly selective, redox-regulated ion channels. Mol Membr Biol 2007; 24: 41-52.
21. Jentsch TJ, Stein V, Weinreich F, Zdebik AA. Molecular structure and physiological function of chloride channels. Physiol Rev 2002; 82: 503-68. (Pubitemid 34654460)
22. Suh KS, Mutoh M, Gerdes M, Yuspa SH. CLIC4, an intracellular chloride channel protein, is a novel molecular target for cancer therapy. J Investig Dermatol Symp Proc 2005; 10: 105-9.
23. Chalothorn D, Zhang H, Smith JE, et al. Chloride intracellular channel-4 is a determinant of native collateral formation in skeletal muscle and brain. Circ Res 2009; 105: 89-98.
24. Fernandez-Salas E, Sagar M, Cheng C, et al. p53 and tumor necrosis factor alpha regulate the expression of a mitochondrial chloride channel protein. J Biol Chem 1999; 274: 36488-97.
25. Stone MJ, Chuang S, Hou X, et al. Tyrosine sulfation: an increasingly recognised post-translational modification of secreted proteins. N Biotechnol 2009; 25: 299-317.
26. Shenkman B, Brill A, Brill G, et al. Differential response of platelets to chemokines: RANTES non-competitively inhibits stimulatory effect of SDF-1 alpha. J Thromb Haemost 2004; 2: 154-60. (Pubitemid 40185632)